Get started
Author

Andrea Duminuco

Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease
2019 · Luca Zanoli, Kadir Ozturk, et al. · Journal of the American Heart Association · 73
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology
2022 · Giuseppe Milone, Claudia Bellofiore, et al. · Journal of Clinical Medicine · 49
PDF
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
2023 · Andrea Duminuco, Helen T. Chifotides, et al. · Cancers · 35
PDF
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future
2023 · Andrea Duminuco, Antonella Nardo, et al. · Journal of Clinical Medicine · 35
PDF
Emergencies in Hematology: Why, When and How I Treat?
2024 · Andrea Duminuco, Vittorio Del Fabro, et al. · Journal of Clinical Medicine · 30
PDF
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
2023 · Andrea Duminuco, Elena Torre, et al. · Current Hematologic Malignancy Reports · 29
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers
2023 · Sebastiano Giallongo, Andrea Duminuco, et al. · Biomolecules · 24
PDF
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
2023 · Giuseppe A. Palumbo, Daniela Cambria, et al. · Frontiers in Oncology · 23
PDF
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study
2022 · Gaetano Giuffrida, Uros Markovic, et al. · Haematologica · 23
PDF
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field
2022 · Andrea Duminuco, Cinzia Maugeri, et al. · Cancers · 23
PDF
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
2021 · Lucia Gozzo, Calogero Vetro, et al. · Frontiers in Pharmacology · 23
PDF
CNS manifestations in acute and chronic graft-versus-host disease
2024 · Nicolas Lambert, Florence Forte, et al. · Brain · 20
Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions
2023 · Andrea Duminuco, Antonella Nardo, et al. · Cancer · 20
PDF
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting
2022 · Andrea Duminuco, Antonella Nardo, et al. · Journal of Clinical Medicine · 20
PDF
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy
2023 · Francesca Palandri, Giuseppe A. Palumbo, et al. · Cancer · 19
PDF
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk
2025 · Andrea Duminuco, Salvatore Scarso, et al. · Annals of Hematology · 17
PDF
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
2025 · Mariarita Spampinato, Cesarina Giallongo, et al. · Journal of Translational Medicine · 17
PDF
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients
2023 · Andrea Duminuco, Salvatore Scarso, et al. · Journal of Clinical Medicine · 17
PDF
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study
2024 · Francesca Palandri, Elena M. Elli, et al. · Cancer · 15
PDF
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms
2024 · Andrea Duminuco, Joshua Au Yeung, et al. · HemaSphere · 14
PDF
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors
2023 · Andrea Duminuco, Calogero Vetro, et al. · Expert Opinion on Pharmacotherapy · 14
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
2023 · Andrea Duminuco, Alessandra Romano, et al. · Frontiers in Oncology · 14
PDF
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project
2023 · Giacomo Coltro, Emanuela Sant'Antonio, et al. · Cancer Medicine · 13
PDF
Revised “iRR6” model in intermediate‐1 risk myelofibrosis patients treated with ruxolitinib
2025 · Francesca Palandri, Filippo Branzanti, et al. · Cancer · 11
PDF
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
2025 · Andrea Duminuco, Raj Vaghela, et al. · Leukemia · 11
PDF
Works count: 132
Citation count: 877
H-index: 17
I10-index: 30
Year
Topic
Type